Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain

By  

Current Drug Targets, Vol. 17, Iss. 2, 2016-02 ,pp. : 178-195

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic polymorphisms related to the renin–angiotensin–aldosterone system and response to antihypertensive drugs

By Taverne Kim   de Groot Mark   de Boer Anthonius   Klungel Olaf  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 4, 2010-04 ,pp. : 439-460

Informa Healthcare

Access to resources Recommend Favorite

Pleiotropic Effects of Drugs Inhibiting the Renin-Angiotensin-Aldosterone System

By  

Current Pharmaceutical Design, Vol. 15, Iss. 5, 2009-02 ,pp. : 571-584

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 981-1004

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs with Blocking Effects on the Renin–Angiotensin–Aldosterone System Do Not Improve Endothelial Dysfunction Long-term in Hypertensive Patients

By Sozen AB   Kayacan MS   Tansel T   Celebi A   Kudat H   Akkaya V   Erk O   Hatipoglu I   Demirel S  

The Journal of International Medical Research, Vol. 37, Iss. 4, 2009-07 ,pp. : 996-1002

Field House Publishing

Access to resources Recommend Favorite